Components of Typhoid Vaccines	Excipients Table Allergens Table Components Table
Indication Induction of active immunity against typhoid fever Proprietary Name Typhim Vi Vivotif Berna Manufacturers sanofi pasteur Berna Viability Inactivated Live, attenuated Microorganism Salmonella enterica serovar typhi, S typhi Ty2 strain Salmonella typhi Ty21a Dose: 0.5 mL  One enteric-coated capsule Route Intramuscular Oral Dose form Liquid solution Capsule Appearance Clear, colorless Salmon/white capsule Concentration Purified Vi polysaccharide, 25 mcg Salmonella typhi Ty21a, 2-6x109 colony-forming units Preservatives Phenol, 0.25% None Adjuvant None None Excipients Sodium chloride, 8.3 mg/mL Disodium phosphate, 0.13 mg/mL Monosodium phosphate, 0.046 mg/mL Polydimethylsilozane-based antifoam agents, residual Sucrose, 26–130 mg Ascorbic acid, 1–5 mg Amino acid mixture, 1.4–7 mg Magnesium stearate 3.6–4.4 mg Allergens None Lactose, 100–180 mg Yeast extract from media Media Semi-synthetic medium without animal proteins Yeast extract (consisting of casein, dextrose and galactose) Packaging Single-dose syringe without needle 20-dose vial Single foil blister contains 4 doses of vaccine Routine Storage 2 to 8° C (36 to 46° F) Do not freeze 2 to 8° C (36 to 46° F) Do not freeze updated August 2005
This page was last updated on August 02, 2010 © 2005 Institute for Vaccine Safety